The House voted to permanently repeal the 2.3% medical device tax, which has been delayed twice but has not yet been successfully repealed.
News & Features
Nevro's stock rebounded after the most recent development in the company's lengthy patent battle with Boston Scientific related to spinal cord stimulation technology.
As its competitor, Terumo, battles with product shortages, Merit Medical saw its growth accelerate in the second quarter and analysts expect the company's good luck to continue.
At least one analyst sees a bright future for Nevro, even if the company is holding the short end of the stick at the conclusion of a longstanding patent dispute with Boston Scientific.
The fourth installment in a series on women in medtech focuses on an entrepreneurial rockstar and her large medtech corporation success story.
The Natick, MA-based company has just completed enrollment in the ENLIGHTEN clinical trial and could have topline results from the study available in 2019.
Personal Genome Diagnostics received a breakthrough device designation from FDA for the PGDx elio plasma resolve liquid biopsy test.
Japan is a major market for medtech companies. Here are the details on how the country's medical reimbursement system works.
Bob Bekian and his company Spotburner are partnering with healthcare firms to produce high quality demonstration videos of medical devices.
CEO Mike Mahoney assured investors that Boston Scientific's seemingly aggressive M&A activity this year has all been part of a "very well-laid plan" and that the company still sees plenty of future tuck-in deals over the next 12 months.
Abbott acquired Tendyne back in 2015, a year where there was significant M&A activity in the transcatheter mitral valve replacement space.
The emergence of electronic healthcare records and recent advancements in computing technology have created the need for Apixio’s artificial intelligence solution.
Intuitive CEO Gary Guthart said global procedure growth was about 18% in the second quarter of 2018 compared with the second quarter of 2017, driven by the acceptance of da Vinci in general surgery in the United States, growth internationally, and appreciation for the company's platform.
New research out of Bentley University aims to explore the genetic links between human DNA and opioid addiction. The new study could help doctors identify patients susceptible to opioid dependence and choose different treatment methods.